238 related articles for article (PubMed ID: 7492334)
1. Characterization of des-(741-1668)-factor VIII, a single-chain factor VIII variant with a fusion site susceptible to proteolysis by thrombin and factor Xa.
Donath MJ; de Laaf RT; Biessels PT; Lenting PJ; van de Loo JW; van Mourik JA; Voorberg J; Mertens K
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):49-55. PubMed ID: 7492334
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of factor VIII light-chain cleavage by thrombin and factor Xa. A regulatory role of the factor VIII heavy-chain region Lys713-Arg740.
Donath MJ; Lenting PJ; Van Mourik JA; Mertens K
Eur J Biochem; 1996 Sep; 240(2):365-72. PubMed ID: 8841400
[TBL] [Abstract][Full Text] [Related]
3. The role of cleavage of the light chain at positions Arg1689 or Arg1721 in subunit interaction and activation of human blood coagulation factor VIII.
Donath MS; Lenting PJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Feb; 270(8):3648-55. PubMed ID: 7876103
[TBL] [Abstract][Full Text] [Related]
4. The effect of von Willebrand factor on activation of factor VIII by factor Xa.
Koedam JA; Hamer RJ; Beeser-Visser NH; Bouma BN; Sixma JJ
Eur J Biochem; 1990 Apr; 189(2):229-34. PubMed ID: 2110896
[TBL] [Abstract][Full Text] [Related]
5. Proteolysis at Arg740 facilitates subsequent bond cleavages during thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
J Biol Chem; 2007 Aug; 282(35):25367-75. PubMed ID: 17595160
[TBL] [Abstract][Full Text] [Related]
6. Identification of a binding site for blood coagulation factor IXa on the light chain of human factor VIII.
Lenting PJ; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1994 Mar; 269(10):7150-5. PubMed ID: 8125924
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
Hill-Eubanks DC; Lollar P
J Biol Chem; 1990 Oct; 265(29):17854-8. PubMed ID: 2120219
[TBL] [Abstract][Full Text] [Related]
8. Activation of factor VIII and mechanisms of cofactor action.
Fay PJ
Blood Rev; 2004 Mar; 18(1):1-15. PubMed ID: 14684146
[TBL] [Abstract][Full Text] [Related]
9. Subunit structure and function of porcine factor Xa-activated factor VIII.
Parker ET; Pohl J; Blackburn MN; Lollar P
Biochemistry; 1997 Aug; 36(31):9365-73. PubMed ID: 9235979
[TBL] [Abstract][Full Text] [Related]
10. Biological activity of recombinant factor VIII variants lacking the central B-domain and the heavy-chain sequence Lys713-Arg740: discordant in vitro and in vivo activity.
Mertens K; Donath MJ; van Leen RW; de Keyzer-Nellen MJ; Verbeet MP; Klaasse Bos JM; Leyte A; van Mourik JA
Br J Haematol; 1993 Sep; 85(1):133-42. PubMed ID: 8251380
[TBL] [Abstract][Full Text] [Related]
11. Cleavage of factor VIII heavy chain is required for the functional interaction of a2 subunit with factor IXA.
Fay PJ; Mastri M; Koszelak ME; Wakabayashi H
J Biol Chem; 2001 Apr; 276(15):12434-9. PubMed ID: 11278520
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
Regan LM; Fay PJ
J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
[TBL] [Abstract][Full Text] [Related]
14. Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII delta II.
Krishnan S; Kolbe HV; Lepage P; Faure T; Sauerwald R; de la Salle H; Muller C; Bihoreau N; Paolantonacci P; Roitsch C
Eur J Biochem; 1991 Feb; 195(3):637-44. PubMed ID: 1900236
[TBL] [Abstract][Full Text] [Related]
15. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin.
Hill-Eubanks DC; Parker CG; Lollar P
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6508-12. PubMed ID: 2505252
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A.
O'Brien DP; Pattinson JK; Tuddenham EG
Blood; 1990 Apr; 75(8):1664-72. PubMed ID: 2109644
[TBL] [Abstract][Full Text] [Related]
17. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
Marquette KA; Pittman DD; Kaufman RJ
Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
[TBL] [Abstract][Full Text] [Related]
18. Cleavage at Arg-1689 influences heavy chain cleavages during thrombin-catalyzed activation of factor VIII.
Newell JL; Fay PJ
J Biol Chem; 2009 Apr; 284(17):11080-9. PubMed ID: 19240027
[TBL] [Abstract][Full Text] [Related]
19. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate.
Neuenschwander PF; Jesty J
Arch Biochem Biophys; 1992 Aug; 296(2):426-34. PubMed ID: 1632634
[TBL] [Abstract][Full Text] [Related]
20. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
